XML 18 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Sep. 30, 2024
Current    
Cash and cash equivalents $ 102,577 $ 132,187
Incentive and tax receivables 809 2,449
Prepaid expenses and other current assets 429 931
Total Assets 103,815 135,567
Current Liabilities    
Accounts payable 4,249 9,627
Accrued liabilities - Note 3 3,892 4,835
Deferred grant income - Note 4 805 842
Total Liabilities 8,946 15,304
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized: 200,000,000 common stock, par value $0.001 per share Issued and outstanding: 86,668,521 common shares (2024 - 84,795,517) 87 85
Additional paid-in capital 477,230 456,249
Accumulated deficit (382,448) (336,071)
Total Stockholders’ Equity 94,869 120,263
Total Liabilities and Stockholders’ Equity $ 103,815 $ 135,567